^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

YT-19/22

i
Other names: YT-19/22, CD19/CD22-Dual-STAR-T
Associations
Trials
Company:
BriSTAR Immunotech
Drug class:
CD19 inhibitor, CD22 inhibitor
Related drugs:
Associations
Trials